Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 294-422-4? Is EINECS 294-422-4 safe for nursing mother and child? Does EINECS 294-422-4 extracts into breast milk? Does EINECS 294-422-4 has any long term or short term side effects on infants? Can EINECS 294-422-4 influence milk supply or can EINECS 294-422-4 decrease milk supply in lactating mothers?

EINECS 294-422-4 lactation summary

EINECS 294-422-4 is safe in breastfeeding
  • DrLact safety Score for EINECS 294-422-4 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of EINECS 294-422-4 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that EINECS 294-422-4 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of EINECS 294-422-4 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 294-422-4 usage in lactation

Natural edulcorant. Widely used by people in Sud-America, China and Japan. It has not been clearly shown to be effective for Diabetes and Arterial Hypertension. Free of toxic effects after a dose of one or two daily cups. Maximal daily dose recommended: 4 mg / kg of body weight

Answer by DrLact: About EINECS 294-422-4 usage in lactation

EINECS 294-422-4 (EINECS 294-422-4 rebaudiana) leaves contain rebaudiosides and steviosides. The EINECS 294-422-4 leaf has been studied for treating diabetes and hypertension, although results are equivocal. EINECS 294-422-4 has no specific lactation-related uses. No data exist on the excretion of any components of EINECS 294-422-4 into breastmilk or on the safety and efficacy of EINECS 294-422-4 in nursing mothers or infants. Rebaudioside A is "generally recognized as safe" (GRAS) as a sweetening agent for foods by the U.S. Food and Drug Administration. Although risk to the breastfed infant appears to be low, an alternate artificial sweetener with more data available may be preferred, especially while nursing a newborn or preterm infant. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.